Literature DB >> 25775563

Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.

Keith H Turner1, Aimee K Wessel1, Gregory C Palmer1, Justine L Murray1, Marvin Whiteley2.   

Abstract

Defining the essential genome of bacterial pathogens is central to developing an understanding of the biological processes controlling disease. This has proven elusive for Pseudomonas aeruginosa during chronic infection of the cystic fibrosis (CF) lung. In this paper, using a Monte Carlo simulation-based method to analyze high-throughput transposon sequencing data, we establish the P. aeruginosa essential genome with statistical precision in laboratory media and CF sputum. Reconstruction of the global requirements for growth in CF sputum compared with defined growth conditions shows that the latter requires several cofactors including biotin, riboflavin, and pantothenate. Comparison of P. aeruginosa strains PAO1 and PA14 demonstrates that essential genes are primarily restricted to the core genome; however, some orthologous genes in these strains exhibit differential essentiality. These results indicate that genes with similar molecular functions may have distinct genetic roles in different P. aeruginosa strains during growth in CF sputum. We also show that growth in a defined growth medium developed to mimic CF sputum yielded virtually identical fitness requirements to CF sputum, providing support for this medium as a relevant in vitro model for CF microbiology studies.

Entities:  

Keywords:  Pseudomonas aeruginosa; Tn-seq; cystic fibrosis; essential genes; sputum

Mesh:

Substances:

Year:  2015        PMID: 25775563      PMCID: PMC4386324          DOI: 10.1073/pnas.1419677112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Essential genes are more evolutionarily conserved than are nonessential genes in bacteria.

Authors:  I King Jordan; Igor B Rogozin; Yuri I Wolf; Eugene V Koonin
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

2.  Comprehensive transposon mutant library of Pseudomonas aeruginosa.

Authors:  Michael A Jacobs; Ashley Alwood; Iyarit Thaipisuttikul; David Spencer; Eric Haugen; Stephen Ernst; Oliver Will; Rajinder Kaul; Christopher Raymond; Ruth Levy; Liu Chun-Rong; Donald Guenthner; Donald Bovee; Maynard V Olson; Colin Manoil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

3.  Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.

Authors:  Kasper N Kragh; Morten Alhede; Peter Ø Jensen; Claus Moser; Thomas Scheike; Carsten S Jacobsen; Steen Seier Poulsen; Steffen Robert Eickhardt-Sørensen; Hannah Trøstrup; Lars Christoffersen; Hans-Petter Hougen; Lars F Rickelt; Michael Kühl; Niels Høiby; Thomas Bjarnsholt
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

4.  Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.

Authors:  K C Meyer; A Sharma; R Brown; M Weatherly; F R Moya; J Lewandoski; J J Zimmerman
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

5.  Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  R F Taylor; M E Hodson; T L Pitt
Journal:  FEMS Microbiol Lett       Date:  1992-05-01       Impact factor: 2.742

6.  Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis.

Authors:  K K Kirchner; J S Wagener; T Z Khan; S C Copenhaver; F J Accurso
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

7.  From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.

Authors:  Svetlana Y Gerdes; Michael D Scholle; Mark D'Souza; Axel Bernal; Mark V Baev; Michael Farrell; Oleg V Kurnasov; Matthew D Daugherty; Faika Mseeh; Boris M Polanuyer; John W Campbell; Shubha Anantha; Konstantin Y Shatalin; Shamim A K Chowdhury; Michael Y Fonstein; Andrei L Osterman
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

8.  Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

Authors:  A L Barth; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.

Authors:  T Brandt; S Breitenstein; H von der Hardt; B Tümmler
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

10.  Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.

Authors:  D E Ohman; A M Chakrabarty
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more
  134 in total

Review 1.  Antibacterial drug discovery in the resistance era.

Authors:  Eric D Brown; Gerard D Wright
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

2.  A Robust CRISPR Interference Gene Repression System in Pseudomonas.

Authors:  Sue Zanne Tan; Christopher R Reisch; Kristala L J Prather
Journal:  J Bacteriol       Date:  2018-03-12       Impact factor: 3.490

3.  Generation of 13C-Labeled MUC5AC Mucin Oligosaccharides for Stable Isotope Probing of Host-Associated Microbial Communities.

Authors:  Clayton Evert; Tina Loesekann; Ganapati Bhat; Asif Shajahan; Roberto Sonon; Parastoo Azadi; Ryan C Hunter
Journal:  ACS Infect Dis       Date:  2019-01-24       Impact factor: 5.084

4.  Transcriptional Responses of Pseudomonas aeruginosa to Potable Water and Freshwater.

Authors:  Erika L English; Kristin C Schutz; Graham G Willsey; Matthew J Wargo
Journal:  Appl Environ Microbiol       Date:  2018-03-01       Impact factor: 4.792

5.  Chemical Genetics Reveals Environment-Specific Roles for Quorum Sensing Circuits in Pseudomonas aeruginosa.

Authors:  Michael A Welsh; Helen E Blackwell
Journal:  Cell Chem Biol       Date:  2016-02-18       Impact factor: 8.116

6.  Fast automated reconstruction of genome-scale metabolic models for microbial species and communities.

Authors:  Daniel Machado; Sergej Andrejev; Melanie Tramontano; Kiran Raosaheb Patil
Journal:  Nucleic Acids Res       Date:  2018-09-06       Impact factor: 16.971

7.  Role of Pseudomonas aeruginosa Glutathione Biosynthesis in Lung and Soft Tissue Infection.

Authors:  Kelly L Michie; Justine L Dees; Derek Fleming; Dina A Moustafa; Joanna B Goldberg; Kendra P Rumbaugh; Marvin Whiteley
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

Review 8.  Bacterial fatty acid metabolism in modern antibiotic discovery.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-23       Impact factor: 4.698

9.  Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics.

Authors:  Lucas A Meirelles; Elena K Perry; Megan Bergkessel; Dianne K Newman
Journal:  PLoS Biol       Date:  2021-03-10       Impact factor: 8.029

Review 10.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.